In the July 13, 2017 issue of The New England Journal of Medicine, leaders in the ALS field, Drs. Robert Brown of University of Massachusetts Medical School and Dr. Ammar Al-Chalabi of King’s College London, came together to write a comprehensive ALS review. The article is far-reaching in that it covers topics from ALS epidemiology, genetics, pathology, identified disease pathways and potential ALS therapies. Familial (inherited) ALS and sporadic (not inherited) ALS are covered.
Both authors Drs. Brown (below left) and Al-Chalabi (below right) are past recipients of our prestigious Sheila Essey Award. The accomplishments of Dr. Brown are numerous, as he is well known for playing a central role in the discovery of many ALS genes, including the first gene identified, SOD1. Dr. Al-Chalabi is a genetics expert, who has also helped identify multiple ALS genes and has made significant contributions to understanding disease staging as Director of King’s MND Care and Research Center. Here we are happy to share their expert insight into all facets of ALS.
Read the article here. Posted with permission from The New England Journal of Medicine.
Amyotrophic Lateral Sclerosis
Brown RH, Al-Chalabi A.
N Engl J Med. 2017 Jul 13;377(2):162-172. doi: 10.1056/NEJMra1603471. Review.